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of chronic liver disease in the Western World [1,2]. There are no
approved pharmacologic therapies for the treatment of NAFLD
[2,3]. NAFLD is considered the hepatic manifestation of metabolic
syndrome and is commonly associated with obesity, and diabetes
[4,5]. Lifestyle interventions such as dietary modiﬁcation to induce
weight loss, and exercise have been shown to be beneﬁcial in
improving NAFLD as well as improve speciﬁc histologic features
associated with the progressive form of NAFLD, which is termed
asnon-alcoholic steatohepatitis (NASH) [6,7]. Therefore,weight loss
in obese and overweight patients with NAFLD is commonly the
recommended management strategy [2]. Both aerobic and
resistance training-based exercise regimen improve liver fat as well
as visceral fat [6]. However, the exact role of the amount and the
intensity of aerobic exercise that would be needed to reverse or
improve NAFLD (or NASH) has not been systematically assessed.
In this issue of the Journal of Hepatology, Keating et al. aimed
to examine the effect of the dose of aerobic exercise training in
improving liver and visceral fat in overweight and obese patients
with NAFLD who had a sedentary lifestyle [8]. Utilizing a
randomized, placebo-controlled clinical trial (RCT) design, the
investigators randomized 48 participants into four equal groups
(n = 12 in each group) receiving various doses/intensities of
exercise training regimen into either; i) low to moderate
intensity, high volume aerobic exercise (LO:HI, 50% VO2peak,
60 min, 4 d/wk); ii) high intensity, low volume aerobic exercise
(HI:LO, 70% VO2peak, 45 min, 3 d/wk); iii) low to moderateJournal of Hepatology 20
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Open access under CC BY-NC-ND license.intensity, low volume aerobic exercise (LO:LO, 50% VO2peak,
45 min, 3 d/wk); or iv) placebo (PLA) for an eight week period.
The primary end point was the change in liver fat as assessed by
magnetic resonance spectroscopy (MRS). The utility of MR-based
liver fat assessment has been previously demonstrated and well-
accepted in early proof of concept trials in NAFLD [9–11] and is
a major strength of this RCT. Authors reported that all three groups
irrespective of the dose of the exercise showed improvement in
liver fat albeit small compared to the PLA-group independent of
weight loss. There were no signiﬁcant differences between the
various aerobic exercise regimens in reducing liver fat over an
8 week period. However, authors conducted additional exploratory
analyses and proposed that there was a trend towards greater
reduction in liver fat and visceral fat in the two groups that utilized
either high intensity with low volume or low intensity with high
volume aerobic exercise. This probably suggests that duration of
exercise and intensity of exercise are both important and one
could perhaps personalize the exercise regimen based upon a
participant’s choice and still achieve similar results.
The study had several strengths including its randomized-
controlled design and the use of MRS to quantify the changes in
liver fat. However, there were a few noteworthy limitations. It
was underpowered for detecting signiﬁcant differences in the efﬁ-
cacy of the various exercise regimens in reducing liver fat content.
Nonetheless, the fact that they were able to demonstrate that all
exercise regimens were able to reduce visceral and liver fat, is
an important practical conclusion. Although 1H-MRS is an accu-
rate method of measuring the amount of fat, either in the liver
or in the adipose tissue, it does not provide information regarding
hepatic necroinﬂammation. Despite these limitations of current
imaging modalities, there is emerging evidence that excess liver
fat per se (independent of NASH) is associated with increased
cardiometabolic risk [12], so the reduction of liver fat may reduce
this excess cardiovascular risk. Exercise is shown to improve
cardiovascular risk in the general population but the exactmecha-
nisms are unknown. It is plausible that exercise reduces cardio-
vascular risk by reducing liver fat as shown in this study.
Further mechanistic studies are needed to test these hypotheses.
Physical activity may have an important role in the prevention
and treatment of NAFLD. Previous studies have shown a15 vol. 63 j 10–12
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consistent association between lack (or lower level) of physical
activity and presence of NAFLD [13,14]. Although the amount of
physical activity that is needed to improve NASH is uncertain
there is preliminary evidence that vigorous exercise may be
associated with a decreased risk of having NASH [15]. The
individual, the joint effect of dose and intensity of exercise and
their association with improvement in liver fat and other
histologic features that are associated with NASH are key
research priorities.
The majority of studies conducted in patients with either
NAFLD or NASH utilize lifestyle interventions that include both
dietary changes and exercise. Therefore, lifestyle intervention
although improve NAFLD and NASH, these are seen with
accompanying weight loss. In a seminal observation, Johnson
et al. showed that aerobic exercise was able to reduce liver fat
in the absence of weight loss. They utilized MRS of the liver to
study 19 sedentary obese individuals for an aerobic exercise
intervention trial with a 4 week duration. They found that aerobic
exercise alone without any signiﬁcant weight loss was able to
induce a 12% decrease in the visceral adipose tissue volume
and a 21% decrease in liver fat content over the 4 week period
[16]. Recently, Sullivan and colleagues conducted a RCT to
evaluate the weight loss-independent effect of following the
physical activity guidelines recommended by the United States
Department of Health and Human Services on liver fat content
and lipid kinetics in obese persons with NAFLD. They
demonstrated that exercise training of moderate intensity for
30–60 min 5 times a week for a 16-week period led to approxi-
mately 10% decrease in liver fat content but did not improve
triglyceride secretion rate in the absence of weight loss [17].
Many of these studies have assessed the utility of aerobic exer-
cise. However, some patients may not be able to either perform
or tolerate aerobic exercise. In those, who are either intolerant
or have contraindications for aerobic exercise, resistance training
may be considered as either aerobic or resistance training which
may induce a reduction in liver fat. In a pilot trial comparing
resistance training vs. controls, resistance training led to a signiﬁ-
cant reduction in liver fat content by induction of hepatic fat oxi-
dation and improvement of glucose control through increases in
the expression of GLUT4 and glycogen synthase [18]. In a recent
trial, Zelber-Sagi and colleagues randomized 62 patients into
either resistance training group or control group and demon-
strated that resistance training can lead to a reduction in liver
fat by using hepatorenal ultrasound index (HRI) [19]. The next
question that emerged from the above studies was to assess if
one type of exercise regimen is better than another in improving
liver fat content. To address some of these issues, Bacchi and col-
leagues randomized 31 sedentary adults with type 2 diabetes and
NAFLD into either aerobic training group or resistance training
group for 4 months. They reported either approach to be equally
effective [20].
In summary, based upon the review of the available evidence,
we offer the following recommendations to the clinicians and the
patients suffering from NAFLD or those who are at risk of NAFLD.
There is good quality evidence to support that regular exercise is
beneﬁcial in reducing the risk of NAFLD. In addition, both aerobic
and resistance training regimen are equally effective in reducing
liver fat in individuals with NAFLD even in the absence of weight
loss. There are no data to support that exercise alone without
weight loss can improve or reverse NASH. Hence, lifestyle
interventions utilizing both exercise and caloric restrictionJournal of Hepatology 20inducing weight loss (loosing approximately 5–10% of body
weight) are needed to improve NASH. The United States
Department of Health and Human Services exercise recommen-
dations may lower liver fat but based upon our expert opinion
more stringent exercise regimen coupled with dietary interven-
tions may be needed to induce improvement in liver histologic
features associated with NASH. Further research is needed to
document the dose, intensity, and joint effect of exercise and
weight loss in improving liver histology in NASH. Although the
minimal effective volume and intensity of exercise are not yet
deﬁned it seems that even low intensity and low volume may
be beneﬁcial – something is better than nothing.Financial support
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